ESOPJul 15, 2026, 05:01 PM
Ascendis Pharma Grants 14,060 Employee Warrants at $265.57 Exercise Price
AI Summary
Ascendis Pharma A/S's board of directors granted 14,060 warrants to certain employees on July 14, 2026. Each warrant allows subscription for one ordinary share at an exercise price of $265.57, matching the closing price on the grant date. The warrants vest 25% after one year, with the remaining 75% vesting monthly over three years, subject to continued service. Following this grant, 1,539,503 additional warrants are available for future grants.
Key Highlights
- Ascendis Pharma's board granted 14,060 warrants to employees on July 14, 2026.
- Each warrant has an exercise price of $265.57 per share, matching the closing price on the grant date.
- Warrants vest 25% on the one-year anniversary of the grant date.
- The remaining 75% vests at a rate of 1/36th per month thereafter, subject to continued service.
- After this grant, 1,539,503 additional warrants remain available for future grants.
- The company amended its Articles of Association to provide for the grant of these Warrants.
Price Impact
More from ASND
Clinical TrialJun 30, 4:11 PM
Ascendis Pharma TransCon CNP shows continued achondroplasia improvements
Clinical TrialJun 30, 8:32 AM
Ascendis Pharma TransCon CNP shows continued TFA improvements at Week 104
Corporate ActionJun 29, 4:07 PM
Ascendis Pharma Issues 177,267 Shares from Warrant Exercise at $121.57